Kura Oncology, Inc.KURANASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-303.63M
↓ 149% vs avg
Percentile
P0
Near historical low
Streak
9 yr
Consecutive declineContracting
Average
$-122.05M
Historical baseline
PeriodValueYoY Change
TTM$-303.63M-57.2%
2024$-193.19M-16.5%
2023$-165.80M-18.5%
2022$-139.87M-6.6%
2021$-131.26M-42.8%
2020$-91.90M-36.2%
2019$-67.48M-7.3%
2018$-62.88M-74.3%
2017$-36.08M-27.2%
2016$-28.37M-